Free Trial
→ The most dangerous moment in a financial crisis (From Weiss Ratings) (Ad)tc pixel

MarketBeat Instant News Alerts

Alkermes logo with Healthcare background

Alkermes (NASDAQ:ALKS) EVP David Joseph Gaffin Sells 2,035 Shares of Stock

MarketBeat

Alkermes plc (NASDAQ:ALKS - Get Free Report) EVP David Gaffin sold 2,035 shares of Alkermes stock in a transaction on Tuesday, November 3rd. The stock was sold at an average price of $46.17, for a total transaction of $93,955.95. Following the sale, the executive vice president directly owned 219,353 shares of the company's stock, valued at $10,127,528.01. This represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NASDAQ:ALKS
Read Alkermes (NASDAQ:ALKS) EVP David Joseph Gaffin Sells 2,035 Shares of Stock
NPK International logo with Industrials background

NPK International (NYSE:NPKI) Director Acquires $138,600.00 in Stock

MarketBeat

NPK International Inc. (NYSE:NPKI - Get Free Report) Director John Minge purchased 15,000 shares of the company's stock in a transaction that occurred on Monday, November 2nd. The stock was bought at an average cost of $9.24 per share, for a total transaction of $138,600.00. Following the purchase, the director directly owned 268,942 shares in the company, valued at $2,485,024.08. This represents a 5.91% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

NYSE:NPKI
Read NPK International (NYSE:NPKI) Director Acquires $138,600.00 in Stock
MARA logo with Technology background

MARA (NASDAQ:MARA) CEO Sells $186,758.95 in Stock

MarketBeat

MARA Holdings (NASDAQ:MARA - Get Free Report) CEO Frederick Thiel sold 27,505 shares of the firm's stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $6.79, for a total value of $186,758.95. Following the completion of the sale, the chief executive officer directly owned 4,149,585 shares of the company's stock, valued at approximately $28,175,682.15. This represents a 0.66% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NASDAQ:MARA
Read MARA (NASDAQ:MARA) CEO Sells $186,758.95 in Stock
Navan logo with Technology background

Navan (NASDAQ:NAVN) CEO Ariel Cohen Sells 8,033 Shares of Company Stock

MarketBeat

Navan, Inc. (NASDAQ:NAVN - Get Free Report) CEO Ariel Cohen sold 8,033 shares of the business's stock in a transaction on Monday, November 2nd. The stock was sold at an average price of $26.13, for a total transaction of $209,902.29. Following the sale, the chief executive officer directly owned 1,027,562 shares in the company, valued at approximately $26,850,195.06. The trade was a 0.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NASDAQ:NAVN
Read Navan (NASDAQ:NAVN) CEO Ariel Cohen Sells 8,033 Shares of Company Stock
Ligand Pharmaceuticals logo with Healthcare background

Ligand Pharmaceuticals (NASDAQ:LGND) Director Sells $224,301.00 in Stock

MarketBeat

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) Director Jason Aryeh sold 700 shares of the stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $320.43, for a total value of $224,301.00. Following the transaction, the director owned 108,758 shares of the company's stock, valued at approximately $34,849,325.94. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

NASDAQ:LGND
Read Ligand Pharmaceuticals (NASDAQ:LGND) Director Sells $224,301.00 in Stock
Adaptive Biotechnologies logo with Healthcare background

Adaptive Biotechnologies (NASDAQ:ADPT) Stock: Insider Julie Rubinstein Sells 11,881 Shares

MarketBeat

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 11,881 shares of the stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $25.47, for a total transaction of $302,609.07. Following the completion of the transaction, the chief operating officer directly owned 377,802 shares of the company's stock, valued at approximately $9,622,616.94. The trade was a 3.05% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NASDAQ:ADPT
Read Adaptive Biotechnologies (NASDAQ:ADPT) Stock: Insider Julie Rubinstein Sells 11,881 Shares

Trending News

1Fermi Advances Project Matador, Pivots to Powered-Land Strategy as Director Vote Fails
2CorMedix (NASDAQ:CRMD) Reaches New 1-Year Low - Here's Why
3Compass Pathways (NASDAQ:CMPS) Stock Falls 7.1% - Should You Sell?
4Cameco Q3 Earnings Call Highlights
5Sandisk Stock Set to Split on Friday, November 20th (NASDAQ:SNDK)
6Sandisk Q1 Earnings Call Highlights
7Americas Gold and Silver (NYSEAMERICAN:USAS) Hits New 52-Week Low - What's Next?
8110,309 Shares of MNTN Inc. $MNTN Bought by One Way Holdings LLC

All MarketBeat Instant News Alerts

MediaAlpha logo with Communication Services background

MediaAlpha (NYSE:MAX) Stock: Insider Kuanling Amy Yeh Sells 25,000 Shares

MarketBeat
NYSE:MAX
Read MediaAlpha (NYSE:MAX) Stock: Insider Kuanling Amy Yeh Sells 25,000 Shares
MediaAlpha logo with Communication Services background

MediaAlpha (NYSE:MAX) CTO Sells 25,000 Shares of Company Stock

MarketBeat
NYSE:MAX
Read MediaAlpha (NYSE:MAX) CTO Sells 25,000 Shares of Company Stock
Replimune Group logo with Healthcare background

Replimune Group (NASDAQ:REPL) Director Kapil Dhingra Sells 21,500 Shares of Stock

MarketBeat
NASDAQ:REPL
Read Replimune Group (NASDAQ:REPL) Director Kapil Dhingra Sells 21,500 Shares of Stock
Ligand Pharmaceuticals logo with Healthcare background

Ligand Pharmaceuticals (NASDAQ:LGND) Director Jason Aryeh Sells 1,411 Shares of Stock

MarketBeat
NASDAQ:LGND
Read Ligand Pharmaceuticals (NASDAQ:LGND) Director Jason Aryeh Sells 1,411 Shares of Stock
Boeing logo with Industrials background

Boeing (NYSE:BA) Stock: Insider Steven Mollenkopf Purchases 2,950 Shares

MarketBeat
NYSE:BA
Read Boeing (NYSE:BA) Stock: Insider Steven Mollenkopf Purchases 2,950 Shares
Rocket Lab logo with Industrials background

Insider Selling: Rocket Lab (NASDAQ:RKLB) Director Sells $576,674.28 in Stock

MarketBeat
NASDAQ:RKLB
Read Insider Selling: Rocket Lab (NASDAQ:RKLB) Director Sells $576,674.28 in Stock
Amalgamated Financial logo with Finance background

Amalgamated Financial (NASDAQ:AMAL) Stock: Insider States Regional Joint Western Sells 16,000 Shares

MarketBeat
NASDAQ:AMAL
Read Amalgamated Financial (NASDAQ:AMAL) Stock: Insider States Regional Joint Western Sells 16,000 Shares
Amalgamated Financial logo with Finance background

Insider Selling: Amalgamated Financial (NASDAQ:AMAL) Major Shareholder Sells $800,320.00 in Stock

MarketBeat
NASDAQ:AMAL
Read Insider Selling: Amalgamated Financial (NASDAQ:AMAL) Major Shareholder Sells $800,320.00 in Stock
Boeing logo with Industrials background

Boeing (NYSE:BA) Director Acquires $998,421.00 in Stock

MarketBeat
NYSE:BA
Read Boeing (NYSE:BA) Director Acquires $998,421.00 in Stock
Amalgamated Financial logo with Finance background

Amalgamated Financial (NASDAQ:AMAL) Major Shareholder Sells 30,000 Shares of Stock

MarketBeat
NASDAQ:AMAL
Read Amalgamated Financial (NASDAQ:AMAL) Major Shareholder Sells 30,000 Shares of Stock
Amalgamated Financial logo with Finance background

Insider Selling: Amalgamated Financial (NASDAQ:AMAL) Major Shareholder Sells 30,000 Shares of Stock

MarketBeat
NASDAQ:AMAL
Read Insider Selling: Amalgamated Financial (NASDAQ:AMAL) Major Shareholder Sells 30,000 Shares of Stock
Amalgamated Financial logo with Finance background

Amalgamated Financial (NASDAQ:AMAL) Major Shareholder Sells 30,000 Shares of Company Stock

MarketBeat
NASDAQ:AMAL
Read Amalgamated Financial (NASDAQ:AMAL) Major Shareholder Sells 30,000 Shares of Company Stock
Amalgamated Financial logo with Finance background

Amalgamated Financial (NASDAQ:AMAL) Major Shareholder United Workers Sells 30,000 Shares of Company Stock

MarketBeat
NASDAQ:AMAL
Read Amalgamated Financial (NASDAQ:AMAL) Major Shareholder United Workers Sells 30,000 Shares of Company Stock
Stride logo with Consumer Discretionary background

Insider Buying: Stride (NYSE:LRN) Director Purchases $2,723,502.87 in Stock

MarketBeat
NYSE:LRN
Read Insider Buying: Stride (NYSE:LRN) Director Purchases $2,723,502.87 in Stock
Stride logo with Consumer Discretionary background

Stride (NYSE:LRN) Director Purchases 54,200 Shares of Company Stock

MarketBeat
NYSE:LRN
Read Stride (NYSE:LRN) Director Purchases 54,200 Shares of Company Stock
Rocket Lab logo with Industrials background

Rocket Lab (NASDAQ:RKLB) CFO Adam Spice Sells 140,157 Shares of Company Stock

MarketBeat
NASDAQ:RKLB
Read Rocket Lab (NASDAQ:RKLB) CFO Adam Spice Sells 140,157 Shares of Company Stock
Kiniksa Pharmaceuticals International logo with Healthcare background

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CEO Sells $8,215,315.38 in Stock

MarketBeat
NASDAQ:KNSA
Read Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CEO Sells $8,215,315.38 in Stock
Kiniksa Pharmaceuticals International logo with Healthcare background

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CEO Sanj Patel Sells 92,891 Shares of Stock

MarketBeat
NASDAQ:KNSA
Read Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CEO Sanj Patel Sells 92,891 Shares of Stock
Stride logo with Consumer Discretionary background

Insider Buying: Stride (NYSE:LRN) Director Buys 137,500 Shares of Stock

MarketBeat
NYSE:LRN
Read Insider Buying: Stride (NYSE:LRN) Director Buys 137,500 Shares of Stock
Kiniksa Pharmaceuticals International logo with Healthcare background

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock: Insider Sanj Patel Sells 220,170 Shares

MarketBeat
NASDAQ:KNSA
Read Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock: Insider Sanj Patel Sells 220,170 Shares
Arista Networks logo with Technology background

Arista Networks (NYSE:ANET) Major Shareholder Sells $45,860,431.48 in Stock

MarketBeat
NYSE:ANET
Read Arista Networks (NYSE:ANET) Major Shareholder Sells $45,860,431.48 in Stock
Curaleaf logo with Healthcare background

Curaleaf (OTCMKTS:CURLF) Announces Earnings Results

MarketBeat
OTCMKTS:CURLF
Read Curaleaf (OTCMKTS:CURLF) Announces Earnings Results
Dana logo with Consumer Discretionary background

Dana Targets $11B Revenue Through Eaton Mobility Deal as Margins Rise

MarketBeat
NYSE:DAN
Read Dana Targets $11B Revenue Through Eaton Mobility Deal as Margins Rise
Huron Consulting Group logo with Industrials background

Huron Consulting Group Q3 Earnings Call Highlights

MarketBeat
NASDAQ:HURN
Read Huron Consulting Group Q3 Earnings Call Highlights

Featured Articles and Offers

A Boeing commercial aircraft parked on a tarmac at sunset, with the Boeing logo overlaid on the sky.
Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
By Dan Schmidt | October 28, 2026
tc pixel
Tesla pays $0 in dividends. This new fund paid $452 in one month on $5,000.
Tesla pays $0 in dividends. This new fund paid $452 in one month on $5,000.
From Investors Alley (Ad)
Phillips 66 logo shown in front of an oil refinery with distillation towers and storage tanks.
Phillips 66 Posts Strong Earnings But the Stock Doesn't Care
By Chris Markoch | October 29, 2026
AbbVie logo over a laboratory scene with vials, a pipette, and a DNA helix illustration.
AbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another Test
By Thomas Hughes | November 2, 2026
Marvell Technology logo and semiconductor chip with a declining stock price chart and server data center.
Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
By Leo Miller | November 1, 2026
tc pixel
Why Gerardo Del Real says wait before buying uranium stocks
Why Gerardo Del Real says wait before buying uranium stocks
From Digest Publishing (Ad)
Nucor logo overlaid on a steel manufacturing plant with rolled steel coils and sheet metal processing equipment.
Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
By Jeffrey Neal Johnson | October 28, 2026
NXP logo on glowing microchip with circuit traces, highlighting semiconductor demand and NXPI stock focus.
NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
By Thomas Hughes | October 29, 2026

Alert Categories

All Alerts
Page 1 of 372